Showing results (221-230 of 405) with videos related to
Sort By:
Pageof 41
Journal of Hazardous Materials|July 17, 2009
Degradation pathways of crystal violet by Fenton and Fenton-like systems: condition optimization and intermediate separation and identificationHuan-Jung Fan, Shiuh-Tsuen Huang, Wen-Hsin Chung, et al.Nuclear Medicine Communications|September 25, 2012
A systematic review and meta-analysis of pretherapeutic lymph node staging of colorectal cancer by 18F-FDG PET or PET/CTYu-Yu Lu, Jin-Hua Chen, Hueisch-Jy Ding, et al.Journal of Hazardous Materials|December 3, 2014
Controlled hydrothermal synthesis of BiOxCly/BiOmIn composites exhibiting visible-light photocatalytic degradation of crystal violetYu-Rou Jiang, Ho-Pan Lin, Wen-Hsin Chung, et al.Frontiers in Genetics|May 28, 2020
Using Genetic Risk Score Approaches to Infer Whether an Environmental Factor Attenuates or Exacerbates the Adverse Influence of a Candidate GeneWan-Yu Lin, Yu-Shun Lin, Chang-Chuan Chan, et al.Applied Radiation and Isotopes : Including Data, Instrumentation and Methods for Use in Agriculture, Industry and Medicine|March 26, 2009
Development of a thermosensitive hydrogel system for local delivery of (188)Re colloid drugsFeng-Yun Huang, Ling-Kuen Huang, Wan-Yu Lin, et al.The Journal of Infectious Diseases|May 23, 2002
Associations between human leukocyte antigen homozygosity and antibody levels to measles vaccineJennifer L St Sauver, Inna G Ovsyannikova, Robert M Jacobson, et al.The Journal of Biological Chemistry|January 13, 2006
Human arsenic methyltransferase (AS3MT) pharmacogenetics: gene resequencing and functional genomics studiesThomas C Wood, Oreste E Salavagionne, Baidehi Mukherjee, et al.Nature Genetics|September 6, 2003
No association of germline alteration of MSR1 with prostate cancer riskLiang Wang, Shannon K McDonnell, Julie M Cunningham, et al.The Prostate|November 6, 2003
Genome linkage screen for prostate cancer susceptibility loci: results from the Mayo Clinic Familial Prostate Cancer StudyJulie M Cunningham, Shannon K McDonnell, Angela Marks, et al.Cancer Research|September 23, 2003
BRAF mutations in colon cancer are not likely attributable to defective DNA mismatch repairLiang Wang, Julie M Cunningham, Jennifer L Winters, et al.Pageof 41